ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Companies News

Biocon Q1 consolidated net profit up 34% to Rs 1,666 million

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Biocon Q1 consolidated net profit up 34% to Rs 1,666 million
IIMBUE 2015 Convenor Harish Mittal (L), Chairman and MD of Biocon India Kiran Mazumdar Shaw (C), Director of IIMB Dr Sushil Vachani (R) during a press conference of IIMBUE 2015 in Bengaluru, on December 3, 2015. Image Source: IANS

India's biotech company Biocon on Thursday reported over 34% rise in the consolidated net profit for the first quarter (Q1) ended on June 30, 2016. 

The company's net profit during the April-June quarter of the fiscal year 2016-17 (FY17) jumped by 34.46% to Rs 1,666 million as against Rs 1,239 million in the April-June quarter of the fiscal year 2015-16 (FY16), Biotech said in a filing to the Bombay Stock Exchange (BSE). 

The Bengaluru-based firm's total net income from operations during the quarter under review surged by 20.70% to Rs 9,824 million as compared to Rs 8,139 million in the same quarter of the previous fiscal.

Its total expenses during the period rose by 18.18% to Rs 7,854 million as against Rs 6,646 million in the corresponding period of last fiscal.

“Our strong performance this quarter has been driven by an all-round growth of our business across small molecules, biologics, branded formulations and research services," Biocon's chairperson and managing director Kiran Mazumdar-Shaw said in a statement. 

The company's biologics business delivered a growth of 53% driven by the sales of biosimilars in emerging markets, she added. 

"The submission of Pegfilgrastim, our first biosimilar filing in EU, is a critical milestone this quarter. Our insulins business made a mark with the launch of Insulin Glargine in Japan," Mazumdar-Shaw said. 

Moreover, the company is on track for filing some of its biosimilars and generic formulations in the developed markets later this year, she noted. 

The stock of Biocon on Thursday closed down 1.21% or Rs 8.60 at Rs 701.50 on the BSE. 

 

 

 

 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Biocon Q1PharmaBiocon Q1 ResultsBiocon Q1 EarningsBombay Stock Exchange (BSE)Kiran Mazumdar-Shaw
Written By: Tejal Yerunkar
Updated: Thu, Jul 21, 2016
09:19 pm
Mumbai , ZeeBiz WebDesk

LATEST NEWS

Honda announces two new electric two-wheelers with swappable batteries, aims to roll out 1 million EVs per year by 2030

Samsung introduces premium range of Robotic, Bespoke vacuum cleaners in India: Check price and other details

Motorola announces new affordable phone with 6.5-inch display in India

Delhi Weather Update: Light rain, thunderstorm lashes capital — Check next 4 days forecast, reason behind sudden weather change

Infosys Q4 results date 2023: When will Infy report earnings?

7th Pay Commission: After DA bonanza, central government employees set to get basic salary increment, to receive Rs 12,604 more in salary

Ram Navami Holiday 2023: These markets, services, won't be available tomorrow

Nifty sheds 431 pts in March F&O series, Nifty Bank slips 91 pts — here's what to expect in April

Investment target under mobile PLI scheme increases to Rs 5,124 crore: MoS IT Rajeev Chandrasekhar

Anil Singhvi strategy March 29: Key market triggers, important levels to track in Nifty50, Nifty Bank today

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. Indiadotcom Digital Private Limited. All Rights Reserved.
LIVE TV